昭衍新药前三季度营收13.35亿元同比降15.87%，净利润 昭衍新药前三季度营收13.35亿元同比降15.87%，净利润-7030.71万元同比降121.46%，毛利率下降16.29个百分点昭衍新药前三季度营收13.35亿元同比降15.87%，净利润-7030.71万元同... 橘子君新闻资讯2024-10-308 阅读0 评论
